 |
||||||||||
| Looking to reach the biopharmaceutical community? | ||||||||||
| July Advertising Opportunities | ||||||||||
| BioPharm International’s audience includes professionals involved in all stages of development and manufacturing of biopharmaceutical therapeutics and diagnostics. With over 31,000 subscribers, we provide the industry with comprehensive coverage of all aspects of biopharmaceutical development, analysis, processing, and packaging, as well as business strategies and regulatory issues (Alliance for Audited Media June 2018 Report). All subscribers meet strict qualification criteria that ensures direct delivery of your advertising message to your target audience. | ||||||||||
| Here is the coverage in the June issue to assist in your decision to advertise with BioPharm International. | ||||||||||
| July Issue | ||||||||||
Focus: Improving Downstream Bioprocess Manufacturing |
||||||||||
Peer-Review: Catalytic-Site-Analysis and Characterization of an Excellent Solvent Tolerant Aldo-Keto Reductase |
||||||||||
Topics: |
||||||||||
| Issue Deadline: June 12 | ||||||||||
| Advertising Opportunities | ||||||||||
| BioPharm International offers multi-platform suite of print, digital, and content marketing solutions. Click here for more info. | ||||||||||
|
||||||||||
| Value Added | ||||||||||
|
||||||||||
 |
||||||||||
| How can we help you reach your marketing goals? Contact your representative to explore options with BioPharm International | ||||||||||
|
||||||||||
| This is a post-only email. Please do not reply, as we will be unable to respond. | |||||||||||
| Please use the links provided if you have questions or concerns regarding this email or your subscription. | |||||||||||
|
